Moolec Science (MLEC) Long-Term Investments (2022 - 2026)
Moolec Science's (MLEC) quarterly Long-Term Investments came in at $16.0 million in Q1 2026, little changed quarter-over-quarter from $16.0 million in Q4 2025.
Moolec Science (MLEC) Long-Term Investments (2022 - 2026) Analysis & Trends
Moolec Science has disclosed Long-Term Investments across 5 years of filings, most recently posting $16.0 million for Q1 2026.
- Long-Term Investments for Q1 2026 came in at $16.0 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $16.0 million (changed N/A YoY), and the FY2024 annual result was $296455.0, down 52.4% from the prior year.
- Long-Term Investments came in at $16.0 million for Q1 2026 at Moolec Science, roughly flat from $16.0 million in the prior quarter.
- In the past five years, Long-Term Investments ranged from a high of $16.0 million in Q4 2025 to a low of -$3.2 million in Q2 2022.
- The 5-year median for Long-Term Investments is $686046.0 (2023), against an average of $5.1 million.
- Across the five-year window, Long-Term Investments plunged 52.4% in 2024 and jumped 2035.41% in 2025, its largest moves.
- Moolec Science's Long-Term Investments stood at -$3.2 million in 2022, then jumped by 119.34% to $622823.0 in 2023, then gained by 20.3% to $749269.0 in 2024, then surged by 2035.41% to $16.0 million in 2025, then changed by 0.0% to $16.0 million in 2026.
- The last three Long-Term Investments figures came in at $16.0 million (Q1 2026), $16.0 million (Q4 2025), and $749269.0 (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | 5.17 Mn |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 5.75 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | - |
| 10 | Moolec Science | 6.98 Bn | 6.98 Bn | - | 16.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.00 Mn |
| Dec 31, 2025 | 16.00 Mn |
| Dec 31, 2024 | 749,269.00 |
| Jun 30, 2024 | 296,455.00 |
| Jun 30, 2023 | 622,823.00 |
| Jun 30, 2022 | -3.22 Mn |